Compound information
- Natural Products
- ZC717319
- Molecular Formula
- C21H33N5O5
- Molecular Weight
- 435.248169156 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-[[(2R)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoyl]amino]-4-methyl-pentanoate
- InChI
- InChI=1S/C21H33N5O5/c1-14(2)12-17(19(28)30-3)25-18(27)16(10-7-11-24-20(22)23)26-21(29)31-13-15-8-5-4-6-9-15/h4-6,8-9,14,16-17H,7,10-13H2,1-3H3,(H,25,27)(H,26,29)(H4,22,23,24)/t16-,17+/m1/s1
- InChI Key
- UIESYHDNHVGZRB-SJORKVTESA-N
- SMILES
- COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)OCc1ccccc1
- Source
- ZINC000005957686
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 155.63 Å2 | LogP | 1.733 |
LogS | -2.432 | LogD | 1.852 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.072 | Pgp substrate | 0.993 |
HIA | 0.495 | F20 % | 0.99 |
F30 % | 0.001 | Caco-2 | -5.681 |
MDCK | -5.484 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.89 | PPB | 55.403 |
VD | 0.562 | Fu | 0.561 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.624 |
CYP2A6 substrate | 0.323 | CYP2B6 substrate | 0.463 |
CYP2C19 inhibitor | 0.149 | CYP2C19 substrate | 0.856 |
CYP2C8 substrate | 0.586 | CYP2C9 inhibitor | 0.225 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.007 |
CYP2D6 substrate | 0.66 | CYP2E1 substrate | 0.271 |
CYP3A4 inhibitor | 0.075 | CYP3A4 substrate | 0.971 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.755 | CL | 5.007 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.616 | Hepatotoxicity | 0.073 |
Mutagenicity | 0.069 | Rat Oral Acute Toxicity | 0.049 |
FDAMDD | 0.282 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.075 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.485 | IGC50 | 2.321 |
LC50FM | 3.722 | LC50DM | 4.286 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.121 | NR-AR-LBD | 0.238 |
NR-AhR | 0.002 | NR-Aromatase | 0.024 |
NR-ER | 0.253 | NR-ER-LBD | 0.36 |
NR-PPAR-gamma | 0.213 | SR-ARE | 0.108 |
SR-ATAD5 | 0.326 | SR-HSE | 0.113 |
SR-MMP | 0.009 | SR-p53 | 0.021 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.